Transcriptomics

Dataset Information

0

Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state


ABSTRACT: Treatment of BRAF-mutant melanomas with MAP-kinase pathway inhibitors is paradigmatic of the promise of precision cancer therapy but also highlights problems with drug resistance that limit patient benefit. We use live-cell imaging, single-cell analysis and molecular profiling to show that exposure of tumor cells to RAF/MEK inhibitors elicits a heterogeneous response in which some cells die, some arrest and a remaining fraction adapts to drug. Drug-adapted cells up-regulate markers of the neural crest (e.g. NGFR), a melanocyte precursor, and grow slowly. To identify genes associated with acquisition of the slowly-cycling, vemurafenib-adapted state, we performed RNA sequencing (RNA-seq) on COLO858 cells (that show the slowly-cycling phenotype) exposed to drug for 24 and 48 h; drug-treated MMACSF cells served as a control. Transcriptional profiling implicates a c-Jun/ECM/FAK/Src cascade in adaptive resistance to RAF inhibition.

ORGANISM(S): Homo sapiens

PROVIDER: GSE87641 | GEO | 2016/12/01

SECONDARY ACCESSION(S): PRJNA345487

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2008-07-25 | GSE8584 | GEO
2021-01-31 | GSE162045 | GEO
2022-08-03 | GSE190936 | GEO
| S-EPMC5248573 | biostudies-literature
| PRJNA1057073 | ENA
2024-04-28 | GSE252002 | GEO
2014-12-21 | E-GEOD-50791 | biostudies-arrayexpress
2006-04-06 | GSE3542 | GEO
2019-09-02 | GSE86385 | GEO
2024-01-02 | GSE235178 | GEO